How Modern Science Is Done

Most people picture science as a lone thinker having a flash of insight. Modern science looks almost nothing like that. It is done by teams, paid for by grants, published under competitive pressure, and increasingly carried out by collaborations too large for any single person to hold in their head.

Understanding this machinery is not cynicism. It helps you read the news wisely: to ask who paid for a study, why a result was rushed to print, and whether one paper is a whole field or a single group's first try. The practice of science shapes its products.

Research groups and funding

The basic unit of academic science is the research group: a senior investigator, several postdoctoral researchers, PhD students, and technicians. Salaries, equipment, and materials are rarely covered by the institution alone. Instead the leader writes grant proposals to funding bodies — government agencies, charities, or companies — competing for money against many other groups. Success rates are often well below one in five.

This has consequences. Time goes into writing proposals rather than experiments. Funders favour projects likely to work, which can crowd out risky ideas. And a group's survival depends on producing results, which is a pressure worth remembering when you read what those results claim.

Collaboration and big science

Many questions are now too large for one group. Big science describes projects that pool hundreds or thousands of researchers, shared instruments, and budgets in the billions. Particle physics at CERN, genome sequencing, and large astronomy surveys all work this way. Papers can carry thousands of named authors.

Big science buys scale and standardised methods, but it is slow, expensive, and hard to steer. It suits problems that need one enormous instrument or a coordinated global effort. It is a poor fit for exploratory work where a small, nimble group can try many ideas cheaply.

Publication, priority, and incentives

Scientists are judged largely by what they publish and where. Priority — being first to report a finding — brings credit, funding, and reputation. This rewards genuine speed and originality, but it also encourages racing, selective reporting of positive results, and a bias toward novel over confirmatory work. The incentives are not evil; they are simply not perfectly aligned with truth, which is exactly why the safeguards you met earlier — replication, peer review, transparency — exist.

A startup announces a 'breakthrough' therapy, citing one small study it funded and published in a minor journal. Reading like a scientist, you note the incentive to promote, the absence of independent replication, and the single small sample. You do not dismiss it — you weight it as a first, interested signal, not a settled result.

Big science is not the only path. In 2012 Jennifer Doudna and Emmanuelle Charpentier, working in relatively modest university labs, published the mechanism that became CRISPR gene editing, sharing the 2020 Nobel Prize in Chemistry. A curiosity-driven, small-group project reshaped biology — a reminder that scale is a tool, not a requirement.

The Human Genome Project set out to read the roughly three billion base pairs of human DNA. It formally began in 1990, was coordinated internationally, and cost on the order of three billion US dollars. The public effort — the International Human Genome Sequencing Consortium, led in the United States by the National Institutes of Health and the Department of Energy, with major work at the UK's Wellcome Trust Sanger Centre and centres in France, Germany, Japan, and China — committed to releasing data freely.

From 1998 a private company, Celera Genomics, led by Craig Venter, pursued a faster shotgun-sequencing approach, turning the project into a widely reported race. In June 2000 the two sides announced a working draft jointly, and initial analyses appeared in early 2001. The project was declared essentially complete in 2003.

The case shows every theme at once: enormous funding, global collaboration, big-science coordination, and the pull of priority and competition. It also shows the system working — data sharing, independent teams, and published methods let the wider community check and build on the result.

• 'Science is done by lone geniuses.' Almost all modern research is done by groups and networks.
• 'Funded research must be biased.' Funding creates incentives to watch for, not automatic falsehood; safeguards exist for this reason.
• 'More authors or money means better science.' Scale suits some problems and wastes effort on others.
• 'Being published first means being right.' Priority rewards speed, which is not the same as being correct.

Take three recent science headlines. For each, find who funded the work, how many groups were involved, and whether the finding has been repeated. Rank them by how much confidence the practice behind them earns.

Think Like a Maester: Before you judge a finding, ask who did it, who paid for it, and what they were racing to be first at.

1. What is a research group, and how is its work usually paid for?
2. What does 'big science' buy, and what does it cost?
3. Why does the reward for priority sometimes pull against careful science?
4. Give one strength and one limitation of large collaborations.
5. In the Human Genome Project, what role did competition and data sharing each play?

Modern science is a social enterprise: groups compete for grants, collaborate at scale, and are rewarded for publishing first. These incentives drive real progress and introduce real pressures. Reading science well means seeing the machinery behind the paper, not just the headline it produced.

• What Is Science?
• Science and Technology